Key Details
Price
$59.66Last Dividend
$0.62Annual ROE
26.48%Beta
0.11Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Oct 31, 2024Recent annual earnings:
Feb 02, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Jan 03, 2025Next split:
N/ARecent split:
Aug 07, 2001Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
The CHMP suggests that Bristol Myers' Opdivo combined with Yervoy should be approved for the initial treatment of hepatocellular carcinoma, as well as Breyanzi for patients with relapsed or refractory follicular lymphoma.
BMY aims to improve its business by relying on the successful launch of new medications. Recent positive news from regulators is also a good sign for the company's stock.
In addition to Wall Street's predictions for Bristol Myers' (BMY) earnings, take a look at forecasts for some important metrics to better understand how the company performed in the quarter that ended in December 2024.
If there were a formal list of important factors for dividend investors to think about before buying a stock, the company's core business would likely be more important than its dividend yield. Still, these two aspects can work together and are not completely separate.
Medicaid funding, which is about $900 billion each year and helps around 72 million people, along with the 340B program, are important areas to consider for possible changes in healthcare.
Our Zacks Earnings ESP makes it simpler to identify stocks that are likely to exceed quarterly earnings predictions.
Bristol Myers (BMY) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.
A lot of stocks do not provide very high returns. For example, the average yield of stocks in the S&P 500 is only 1.3%.
On the most recent trading day, Bristol Myers Squibb (BMY) closed at $60.62, which is an increase of 1.59% compared to its last closing price.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASCO--BMS has shared findings from the CheckMate -8HW study.
FAQ
- What is the primary business of Bristol-Myers Squibb?
- What is the ticker symbol for Bristol-Myers Squibb?
- Does Bristol-Myers Squibb pay dividends?
- What sector is Bristol-Myers Squibb in?
- What industry is Bristol-Myers Squibb in?
- What country is Bristol-Myers Squibb based in?
- When did Bristol-Myers Squibb go public?
- Is Bristol-Myers Squibb in the S&P 500?
- Is Bristol-Myers Squibb in the NASDAQ 100?
- Is Bristol-Myers Squibb in the Dow Jones?
- When was Bristol-Myers Squibb's last earnings report?
- When does Bristol-Myers Squibb report earnings?
- Should I buy Bristol-Myers Squibb stock now?